Press release
08.03.2021 To the attention of interested persons EMA press release: EMA issues advice on use of antibody combination (bamlanivimab / […]
Press release
04.03.2021 To the attention of interested persons EMA press release: EMA starts rolling review of the Sputnik V COVID-19 vaccine […]
Press release
04.03.2021 To the attention of interested persons The NAMMDR took note of the existence in the public space of some […]
Press release
03.03.2021 To the attention of interested persons EMA press release: Adapting COVID-19 vaccines to SARS-CoV-2 variants: guidance for vaccine manufacturers […]
Press release
23.02.2021 To the attention of interested persons EMA press release: EMA starts evaluating use of Veklury in COVID-19 patients not […]
Press release
23.02.2021 To the attention of interested persons EMA press release: Precautionary marketing suspension of thalassaemia medicine Zynteglo download document …
Important notification
22.02.2021 To the attention of Marketing Authorisation Holders UK withdrawal from the European Unit On the 31st December 2020, the […]
Press release
18.02.2021 To the attention of interested persons EMA press release: EMA receives application for conditional marketing authorisation of COVID-19 Vaccine […]
Press release
16.02.2021 To the attention of interested persons EMA press release: Review of amfepramone medicines started download document …
Important notification
15.02.2021 To the attention of marketing authorisation holders Request for assessment of the risk of the presence of nitrosamine impurities […]